Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice

European Neuropsychopharmacology

Volumn 6, Issue 2, 1996, Pages 135-140

  Budziszewska, B ^a   Jaworska Feil, L ^a   Lason W ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Mice; Morphine withdrawal; Naloxone; Neurosteroids

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; CORTICOSTERONE; DEOXYCORTICOSTERONE ACETATE; MORPHINE; NALOXONE; NEUROSTEROID; PRASTERONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BODY WEIGHT; DRUG DEPENDENCE; DRUG THERAPY; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030063961     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(96)00003-X     Document Type: Article

References (32)

1. Aghajanian, G.K. (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276, 186-188.
2. Barnea, A., Hajibeigi, A., Trant, J.M. and Mason, J.I. (1990) Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: A model for developmental regulation of the progesterone 5α-reductase pathway. Endocrinology 127, 500-502.
3. Belelli, D. and Gee, K.W. (1989) 5α-Pregnan-3α,20α-diol behaves like a partial agonist in the modulation of GABA-stimulated chloride ion uptake by synaptoneurosomes. Eur. J. Pharmacol. 167, 173-176.
4. Belelli, D., Bolger, M.B. and Gee, K.W. (1989) Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166, 325-329.
5. Belelli, D., Lan, N.C. and Gee, K.W. (1990) Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev. 14, 315-322.
6. Ben-Nathan, D., Kobiler, D., Feuerstein, G. and Lustig, S. (1992) Antistress effect of dehydroepiandrosterone (DHEA) on mice inoculated with attenuated arboviruses. Progr. NeuroEndocrinImmunol. 5, 229-234.
7. Bowlby, M.R. (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43, 813-819.
8. Budziszewska, B., Jaworska, L. and Lasoń, W. (1995) Repeated morphine administration down-regulates glucocorticoid, but not mineralocorticoid, receptors in the rat hippocampus. Psychoneuroendocrinology 20, 75-81.
9. Cappendijk, S.L.T., de Vries, R. and Dzoljic, M.R. (1993) Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur. Neuropsychopharmacol. 3, 111-116.
10. Cheng, Y.-J. and Karavolas, H.J. (1973) Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medial basal hypothalami and the effects of estradiol and stage of estrus cycle on the conversion. Endocrinology 93, 1157-1162.
11. Corpechot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J.N., Touyer, G., Mouren, M., Prasad, V.V.K., Banner, C., Sjovall, J., Baulieu, E.E. and Robel, P. (1993) Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133, 1003-1009.
12. Crawley, J.N., Glowa, J.R., Majewska, M.D. and Paul, S.M. (1986) Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398, 382-385.
13. Daniell, L.C. and Harris, R.A. (1988) Neuronal intracellular calcium concentrations are altered by anesthetics: relationship to membrane fluidization. J. Pharmacol. Exp. Ther. 245, 1-7.
14. Eisenberg, R.M. (1985) Effects of chronic treatment with diazepam, phenobarbital, or amphetamine on naloxone-precipitated morphine withdrawal. Drug Alcohol Depend. 15, 375-381.
15. Gee, K.W., Bolger, M.B., Brinton, R.E., Coirini, H. and McEwen, B.S. (1988) Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246, 803-812.
16. A receptor function. Mol. Pharmacol. 46, 977-985.
17. Irwin, R.P., Lin, S.-Z., Rogawski, M.A., Purdy, R.H. and Paul, S.M. (1994) Steroid potentiation and inhibition of N-methyl-D-aspartate receptor mediated intracellular Ca response: structure-activity studies. J. Pharmacol. Exp. Ther. 271, 677-682.
18. Karavolas, H.J. and Herf, S.M. (1971) Conversion of progesterone by rat medial basal hypothalamic tissue to 5α-pregnane-3,20-dione. Endocrinology 89, 940-942.
19. Kokate, T.G., Svensson, B.E. and Rogawski, M.A. (1994) Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270, 1223-1229.
20. Kubli-Garfias, C. (1984) Physiological role of 5α- and 5β-progesterone metabolites on the CNS. Trends Pharmacol. Sci. 5, 439-442.
21. A receptor. In Costa, E. and Paul, S.M. (Eds.), Neurosteroids and Brain Function, Fidia Research Foundation Symposium Series Vol. 8, Thieme Medical, New York, pp. 109-117.
22. McEwen, B. (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12, 141-146.
23. Owens, M.J., Ritchie, J.C. and Nemeroff, C.B. (1992) 5α-Pregnane-3α,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam. Brain Res. 573, 353-355.
24. P'an, S.Y. and Laubach, G.D. (1964) Steroid central depressants. In Dorfman, R.I. (Ed.), Methods in Hormone Research, Academic Press, New York, pp. 415-475.
25. Patchev, V.K., Shoaib, M., Holsboer, F. and Almeida, O.F.X. (1994) The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62, 265-271.
26. Paul, S.M. and Purdy, R.H. (1992) Neuroactive steroids. FASEB J. 6, 2311-2322.
27. Przegaliński, E., Budziszewska, B. and Grochmal, A. (1992) Effect of adenosine analogues on plasma corticosterone concentration in rats. Acta Endocrinol. 127, 471-475.
28. Redmond, D.E. and Krystal, J.H. (1984) Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7, 443-478.
29. Schwarz, S. and Pohl, P. (1994) Steroids and opioid receptors. J. Steroid Biochem. Mol. Biol. 48, 391-402.
30. Trujillo, K.A. and Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
31. Vetulani, J. and Bednarczyk, B. (1977) Depression by clonidine of shaking behavior elicited by nalorphine in morphine-dependent rats. J. Pharm. Pharmacol. 29, 567-569.
32. Wieland, S., Lan, N.C., Mirasedeghi, S. and Gee, K.W. (1991) Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 565, 263-268.